FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Furlow Brenda S.   2. Issuer Name and Ticker or Trading Symbol BIO-TECHNE Corp [TECH] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) SVP - General Counsel (Last) (First) (Middle) 614 MCKINLEY PLACE NE 3. Date of Earliest Transaction (Month/Day/Year) 08/07/2018 (Street) MINNEAPOLIS, MN 55413 4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 08/07/2018   M   959 A $ 0 2,627 D   Common Stock 08/07/2018   F   438 D $ 180.14 2,189 D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Underlying Securities (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	08/07/2018		M			959	(2)	(2)	Common Stock	959	$ 0	241	D
Restricted Stock Units	(1)	08/07/2018		D			241	(2)	(2)	Common Stock	241	$ 0	0	D
Stock Options (Right to buy)	$ 108.49	08/07/2018		D			1,505	(3)	08/07/2022	Common Stock	1,505	$ 0	5,995	D
Restricted Stock Units	(1)	08/08/2018		A		1,374		(4)	(4)	Common Stock	1,374	$ 0	1,374	D
Stock Options (Right to buy)	$ 177.32	08/08/2018		A		9,786		(5)	08/08/2025	Common Stock	9,786	$ 0	9,786	D
Stock Options (Right to buy)	$ 177.32	08/08/2018		A		7,339		(4)	08/08/2025	Common Stock	7,339	$ 0	7,339	D
Restricted Stock Units	(1)							(6)	(6)	Common Stock	1,759		1,759	D
Restricted Stock Units	(1)							(7)	(7)	Common Stock	1,724		1,724	D
Stock Option (Right to Buy)	$ 108.49							(8)	08/07/2022	Common Stock	10,000		10,000	D
Stock Option (Right to Buy)	$ 94.35							(9)	08/12/2021	Common Stock	15,000		15,000	D
Stock Options (Right to buy)	$ 125.05							(7)	08/09/2024	Common Stock	9,503		9,503	D
Stock Options (Right to buy)	$ 125.05							(10)	08/09/2024	Common Stock	12,760		12,760	D
Stock Options (Right to buy)	$ 106.59							(11)	08/18/2023	Common Stock	14,476		14,476	D
Stock Options (Right to buy)	$ 106.59							(6)	08/18/2023	Common Stock	10,857		10,857	D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Furlow Brenda S. 614 MCKINLEY PLACE NE MINNEAPOLIS, MN 55413			SVP - General Counsel

Signatures

/s/ Anna Weispfenning as Attorney-in-Fact for Brenda S. Furlow pursuant to Power of Attorney previously filed.		08/09/2018
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
(10)	Vest 3,167 shares each on 8/9/2018, 8/9/2019 and 3,168 shares each on 8/9/2020, 8/9/2021.
(11)	Vests 3,619 shares on each of 8/18/17, 8/18/18, 8/18/19 and 8/18/20.
(2)	On 8/7/2018, the Board of Directors authorized discretionary vesting for 959 performance RSUs. The remainder of the performance RSUs were forfeited.
(3)	On 8/7/2018, the Board of Directors authorized discretionary vesting for 5,995 performance options. The remainder of the performance options were forfeited.
(4)	Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
(5)	Vests 2,447 shares each on 8/8/2019, 8/8/2020, and 2,446 shares each on 8/8/2021, 8/8/2022
(6)	Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
(7)	Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
(8)	2,500 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.
(9)	3,750 shares vest on each of 8/12/15, 8/12/16, 8/12/17 and 8/12/18.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.